← Back to Search

Exercise or Education Programs for Fatigue and Pain in Breast Cancer Survivors

N/A
Waitlist Available
Research Sponsored by Clayton State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female
Breast cancer survivor who received adjuvant chemotherapy or radiotherapy for breast cancer only
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will compare an exercise program, health education program, or no program to see which is most effective in reducing fatigue and pain in breast cancer survivors.

Who is the study for?
This trial is for English-reading female breast cancer survivors who finished chemo or radiotherapy 2-6 months ago, with hemoglobin levels of at least 11 g/dL. It's not suitable for those with heart issues, multiple cancers, severe obesity or anorexia, uncontrolled hypertension, major respiratory diseases, acute illnesses like fever or infections.Check my eligibility
What is being tested?
The study is comparing the effectiveness of an exercise program against a health education program and no intervention in reducing fatigue and pain to improve quality of life in breast cancer survivors.See study design
What are the potential side effects?
Since this trial involves exercise and educational programs rather than medication, side effects may include typical exercise-related discomforts such as muscle soreness. The health education program should not have direct physical side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.
Select...
I had chemotherapy or radiotherapy for breast cancer.
Select...
I finished my treatment between 2 to 6 months ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

Clayton State UniversityLead Sponsor
Melanie Poudevigne, PhDStudy ChairClayton State University

Media Library

Exercise Program Clinical Trial Eligibility Overview. Trial Name: NCT00336089 — N/A
Breast Cancer Research Study Groups:
Breast Cancer Clinical Trial 2023: Exercise Program Highlights & Side Effects. Trial Name: NCT00336089 — N/A
Exercise Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT00336089 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this investigation still ongoing?

"Unfortunately, this research trial is not presently enrolling patients. The study was initially submitted on January 1st 2006 and its latest update was posted September 16th 2013, yet there are still 3146 other trials that require volunteers at the moment."

Answered by AI

Does this trial permit persons aged 35 or older to participate?

"The eligibility criteria for this study requires that participants are between 18 and 60 years of age."

Answered by AI

Who are the appropriate candidates for participation in this experiment?

"This clinical study seeks to enroll 54 patients who have recently been treated for breast cancer and are aged between 18-60 years old. Additionally, participants must not be suffering from unstable heart disease or angina, nor any chronic respiratory disorder. Hormone receptor status and menopausal status are not specified criteria for entry into the trial."

Answered by AI
~3 spots leftby Apr 2025